← FDA Drug Approvals (Drugs@FDA)

MONTELUKAST SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RISING · Approved 2017-04-24

Drug application

FDA Application #
ANDA209012
Application type
Abbreviated New Drug Application (Generic)
Brand name
MONTELUKAST SODIUM
Generic name
MONTELUKAST SODIUM
Active ingredients
MONTELUKAST SODIUM
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
RISING
Manufacturer
Rising Pharma Holdings, Inc.
First approval
2017-04-24

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown